Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 13 symbols : Mrk save search
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Published: 2021-05-13 (Crawled : 13:00) - prnewswire.com
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -0.14%
H: 1.41%
C: 1.03%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.49%
H: 2.01%
C: 1.4%
CMPS | $8.07 -2.18% -2.23% 890K
|
Health Technology
|
| O: 4.4%
H: 0.0%
C: -10.26%
fda test research fda approval approval
Merck Announces Phase 3 KEYNOTE-522 Trial Met Dual Primary Endpoint of Event-Free Survival (EFS) in Patients With High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC)
Published: 2021-05-13 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: -0.14%
H: 1.41%
C: 1.03%
risk cancer phase 3 breast cancer trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.